Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Prices Senior Notes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today priced its previously announced senior notes being issued to partially fund its $3.5 billion purchase of Phadia.

In total, the company is offering $2.1 billion in senior notes — $1 billion worth of 2.25 percent notes due 2016 at an issue price of 99.826 percent of the principal amount, and $1.1 billion of 3.6 percent notes due in 2021 at an issue price of 99.809 percent of the principal amount.

The issuance of the notes is expected to close on Aug. 16 and will pay interest on a semi-annual basis.

Ratings firm Fitch yesterday assigned an "A-" rating to the notes.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.